MYC and neoplasm: Considering that Notch pathway loss-of-function mutations have been reported in approximately 25% of human SCLCs [12], it has been proposed that SCLC tumor cells with defective Notch signaling remain in an NE-high state, while tumor cells with intact and activated Notch are reprogrammed by MYC to a non-NE state.